scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1000467499 |
P356 | DOI | 10.1038/BMT.2015.333 |
P698 | PubMed publication ID | 26808569 |
P2093 | author name string | M Brown | |
D Myers | |||
M Radhi | |||
N Shreve | |||
R Rahmetullah | |||
P2860 | cites work | Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia | Q33392788 |
Telomere diseases | Q36107376 | ||
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita | Q36691743 | ||
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita | Q37077955 | ||
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita | Q42839610 | ||
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. | Q46177519 | ||
Dyskeratosis Congenita (DC) Registry: identification of new features of DC. | Q50848237 | ||
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. | Q53330217 | ||
Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen | Q56970257 | ||
Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation | Q61853258 | ||
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita | Q63384262 | ||
Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience | Q73185895 | ||
Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita | Q82984194 | ||
P433 | issue | 5 | |
P921 | main subject | dyskeratosis congenita | Q3709312 |
P304 | page(s) | 744-746 | |
P577 | publication date | 2016-01-25 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita | |
P478 | volume | 51 |